Reuters logo
BRIEF-Can-Fite concludes successful clinical investigator meeting for its acrobat phase III trial of Piclidenoson
June 8, 2017 / 11:23 AM / 6 months ago

BRIEF-Can-Fite concludes successful clinical investigator meeting for its acrobat phase III trial of Piclidenoson

June 8 (Reuters) - Can Fite Biopharma Ltd

* Can-Fite concludes successful clinical investigator meeting for its acrobat phase III trial of piclidenoson in the treatment of rheumatoid arthritis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below